YUCAIPA, Calif., April 1, 2011 (GLOBE NEWSWIRE) -- Ingen Technologies, Inc. (Pink Sheets:IGNT), an ISO 13485:2003 certified medical device manufacturer of respiratory medical devices, announced today that the Chairman & COO, Gary Tilden, was interviewed by Wall Street Reporter Senior Analyst Juan Costello.
This interview was conducted on March 30, 2011. In the interview Gary Tilden describes the current and future outlook of Ingen Technologies for potential investors. In addition, Mr. Tilden explained the Impact of Ingen's latest news development, his viewpoint on opportunities and challenges within the respiratory industry, and how we are positioning the company. Furthermore, they discussed the overview of the company's products/services/projects, progress to date, and future growth strategy.
"I was pleased to share some of Ingen's current events with potential shareholders and prospective investment people and I am always open to offering my assistance to anyone interested in our products and where Ingen is headed," stated Gary Tilden, Chairman and COO.
If you would like to hear this interview live on your computer via MP3, go to the following link:
Once you have linked to the WALLSTREET REPORTER website, below the INGEN TECHNOLOGIES Logo press the forward box to begin the MP3 recording. Be sure you have your speakers on.
About Ingen
Our wholly owned subsidiary is an established ISO certified medical device manufacturer with an emerging new medical product line for the respiratory market worth an estimated $4 Billion in the US, and $8 billion globally. Visit www.ingen-tech.com.
The Ingen Technologies, Inc. logo is available at
Safe Harbor for Forward-Looking Statements: This news release includes forward-looking statements. While these statements are made to convey to the public the company's progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management's opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The company's operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ are and will be set forth in the company's periodic filings with the U.S. Securities and Exchange Commission.
CONTACT: Gary Tilden, Chairman 909-790-7180 www.INGEN-TECH.COM info@ingen-tech.com
